Latest filing published 22 Sept 2015 for Akari Therapeutics Plc, €175k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark S. Cohen: trading record in brief
Mark S. Cohen discloses dealings in Akari Therapeutics PLC to SEC (Form 4). The record holds 3 filings, for trades running from 8 January 2015 to 18 September 2015.
On the market, this insider has only ever bought: 1 purchase, €175k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
On 22 September 2015 came the latest disclosure, an open-market purchase for €175k in Akari Therapeutics PLC. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark S. Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,055,600 shares@ US$0.1895Ordinary SharesSEC:0001144204-15-055967:0Canonical exit: 17 Dec 2015 (T+90)
- 50,700 shares@ US$0.0167Ordinary SharesSEC:0001144204-15-001832:0
- 152,000 shares@ US$0.0153Ordinary SharesSEC:0001144204-15-001832:1
3 of 3 declarations
